關鍵數據
18.330今開
19.290最高
170.49K成交量
虧損本益比TTM
179.18本益比動
--股利TTM
1.28%換手率
18.070昨收
17.870最低
2.61M成交額
虧損本益比靜
1.92市淨率
0.00%股息率 TTM
-5.99%ROA
16.24052週最高
2.20量比
-56.38M淨利潤
13.36M總股本
-0.7916每股盈餘TTM
0.22Beta
-7.85%ROE
7.87052週最低
7.86%振幅
65.15%毛利率
257.12M總市值
6.17回報/風險
2.86%風險率
操作建議
Anika Therapeutics Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名6/199位。機構持股佔比非常高,近一月多位分析師給出公司評級為強力買入。最高目標價為19.00。中期看,股價處於上升通道。近一個月,市場表現很強,基本面評分較高,但很強的走勢沒有得到技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Anika Therapeutics Inc評分
壓力支撐

由於公司未披露,未能獲取相關數據
Anika Therapeutics Inc亮點
亮點風險
Anika Therapeutics Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Anika Therapeutics Inc
ANIK
2
Zimmer Biomet Holdings Inc
ZBH
31
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Anika Therapeutics Inc簡介
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
公司代碼ANIK
公司Anika Therapeutics Inc
CEOBlanchard (Cheryl Renee)
網址https://anika.com/
公司股東
常見問題
Anika Therapeutics Inc(ANIK)的當前股價是多少?
Anika Therapeutics Inc(ANIK)的當前股價是 19.25。
Anika Therapeutics Inc 的股票代碼是什麼?
Anika Therapeutics Inc的股票代碼是ANIK。
Anika Therapeutics Inc股票的52週最高點是多少?
Anika Therapeutics Inc股票的52週最高點是16.24。
Anika Therapeutics Inc股票的52週最低點是多少?
Anika Therapeutics Inc股票的52週最低點是7.87。
Anika Therapeutics Inc的市值是多少?
Anika Therapeutics Inc的市值是257.12M。
現在Anika Therapeutics Inc(ANIK)的股票是買入、持有還是賣出?
根據分析師評級,Anika Therapeutics Inc(ANIK)的總體評級為STRONG BUY,目標價格為19.00。
Anika Therapeutics Inc(ANIK)股票的每股收益(EPS TTM)是多少
Anika Therapeutics Inc(ANIK)股票的每股收益(EPS TTM)是-0.76。